Mode
Text Size
Log in / Sign up

Computational platform expands genetic screening scope in high-consanguinity Gulf populations

Computational platform expands genetic screening scope in high-consanguinity Gulf populations
Photo by Dmytro Vynohradov / Unsplash
Key Takeaway
Note: Projected screening benefits are from economic modeling, not clinical trial data.

This study describes the development and economic modeling of the SafeGene computational platform for predictive genetic screening. The analysis focuses on populations in Saudi Arabia and the Gulf region, which have high consanguinity rates (50-58%) and elevated carrier frequencies for certain recessive disorders. The platform is designed to screen for 50 genetic conditions across 12 categories, expanding upon the existing premarital screening program that screens for only two conditions.

The main results are based on platform validation and economic modeling. The platform demonstrated concordance with observed disease frequencies from published data. Economic modeling projects that implementing this expanded screening could prevent 2,800-4,200 affected births annually, with projected annual savings of SAR 1.2-2.8 billion ($320-746 million USD).

Safety and tolerability data were not reported. Key limitations include that the platform is described but not tested in a clinical population, and the projected prevented births and savings are from economic modeling rather than prospective implementation. Validation was performed against published data rather than through a prospective clinical study.

Practice relevance is not reported. The findings represent a theoretical expansion of screening scope and projected benefits based on modeling assumptions. Clinicians should interpret these projections cautiously as they are not derived from clinical trial evidence of platform implementation or patient outcomes.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
BackgroundSaudi Arabia bears a disproportionate burden of autosomal recessive genetic disorders, driven by consanguineous marriage rates of 50-58% and elevated carrier frequencies for conditions such as sickle cell disease (carrier rate up to 25%), betathalassemia (12%), and spinal muscular atrophy (6%). The existing premarital screening program screens for only two conditions. We developed SafeGene, a computational platform that expands predictive genetic screening to 50+ conditions using regionspecific population genetics. MethodsSafeGene integrates five risk calculation engines: (1) Mendelian inheritance models for AR, AD, XR, and XD conditions; (2) HardyWeinberg equilibriumbased carrier probability estimation using Saudi, Gulf, and global databases; (3) a sixlevel consanguinity coefficient calculator (F = 0 to 1/8) with risk amplification multipliers; (4) multifactorial polygenic risk models for 12 complex diseases; and (5) maternal agedependent trisomy risk curves. Built using React.js, Node.js/Express, and MongoDB with bilingual Arabic/English support. ResultsThe platform encompasses 50 genetic conditions across 12 categories. Validation against published Saudi data demonstrated concordance with observed disease frequencies. Economic modeling projects that expanding screening could prevent 2,800-4,200 affected births annually, yielding savings of SAR 1.2-2.8 billion ($320-746 million USD) per year. ConclusionsSafeGene represents a scalable, evidencebased digital health solution for comprehensive genetic screening addressing the unique population genetics of consanguineous Gulf societies. The platform is protected under pending patent applications in South Africa (CIPC) and Saudi Arabia (SAIP).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.